PATENT CLAIM ANALYSIS

Application Number: 15990170
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["424", "164100"]

Abstract:
The present invention concerns the use of an inhibitor of an interaction between type IV pilus-associated protein and CD147 for preventing or treating meningoccal bacteraemia and/or infection. The present invention also relates to the combined use of such inhibitor and of an anti-bacterial compound, such as one used to prevent or treat a meningococcal infection. The invention also relates to a method for the prevention and/or treatment of meningococcal bacteraemia and/or infection, and to a method for screening inhibitors of the interaction between type IV pilus-associated protein and CD147.

Claim (Index 7):
The method according to  claim 6 , wherein said anti-bacterial compound is selected from the group consisting of meningococcal PilE, PilV, PilX, PilC, ComP, fHbp, PorA, NHBA, NadA, MafA, NspA, HmbR, TbpB, and AusP, or an immunogenic fragment thereof.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 93.0
- Lexical Diversity: 2.04348
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14405444', '12004869', '12355689', '11776709', '13508181']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6932079546129627
- 35 USC 102 Novelty (BERT): 0.6328828719436634
- Combined Prediction Score: 0.6871754463460328
- Mean Citation Score: 320.113952
- Max Citation Score: 697.1454
- Similarity Product: 506.27620349850656

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test